---
category: listing
circular_id: 35ef025d79db6e2e
date: '2025-12-16'
description: Shareholding pattern disclosure for Nephrocare Health Services Private
  Limited post-IPO listing on NSE, showing promoter holding of 63.85% and public holding
  of 36.15%.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML71834.zip
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Standard IPO listing notification with shareholding pattern disclosure;
  relevant for investors tracking new listings and ownership structure
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML71834.zip
processing:
  attempts: 1
  content_hash: 77f2e1e70568671b
  processed_at: '2025-12-16T15:59:38.956971'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-16T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML71834.zip
severity: medium
source: nse
stocks:
- NEPHROCARE
tags:
- listing
- ipo
- shareholding-pattern
- nephrocare
- equity-shares
- promoter-holding
- public-holding
title: Listing of Equity Shares of Nephrocare Health Services Limited (IPO)
---

## Summary

Nephrocare Health Services Private Limited has listed its equity shares on NSE following an IPO. The shareholding pattern filed under Regulation 31(1)(a) as of December 16, 2025, shows total issued capital of 100,340,717 equity shares with promoter and promoter group holding 63.85% and public shareholders holding 36.15%.

## Key Points

- Total number of shareholders: 212,979 (10 promoters and 212,969 public shareholders)
- Total equity shares issued: 100,340,717 fully paid-up shares
- Promoter & Promoter Group holding: 64,072,206 shares (63.85%)
- Public holding: 36,268,511 shares (36.15%)
- Outstanding convertible securities: 3,180,045 shares
- Fully diluted share capital: 103,520,762 shares
- Dematerialized shares: 83,409,664 shares (83.13% of total)
- No partly paid-up shares, warrants, depository receipts, or ESOPs outstanding
- No shares are locked-in, pledged, or under non-disposal undertaking
- No shares with differential voting rights or significant beneficial owners

## Regulatory Changes

No regulatory changes introduced. This is a standard shareholding pattern disclosure required under SEBI regulations for newly listed companies.

## Compliance Requirements

- Companies must file shareholding pattern under Regulation 31(1)(a) post-listing
- Disclosure must include details of promoter holdings, public holdings, and any encumbrances
- All equity shares must be accounted for with proper categorization

## Important Dates

- Post-issue date: December 16, 2025
- Shareholding pattern filing date: December 16, 2025

## Impact Assessment

**Market Impact**: Medium - New listing provides investment opportunity in healthcare services sector. The high promoter holding (63.85%) indicates strong promoter commitment, while adequate public float (36.15%) ensures liquidity.

**Investor Impact**: Medium - Investors can now trade Nephrocare shares on NSE. The shareholding structure shows no encumbrances or locked-in shares that could affect trading.

**Operational Impact**: Low - Standard listing process with no unusual conditions or restrictions on trading.